Jpmorgan Chase & CO Liva Nova PLC Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LIVN
# of Institutions
261Shares Held
52.9MCall Options Held
316KPut Options Held
127K-
Black Rock Inc. New York, NY6.9MShares$325 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.63MShares$265 Million0.22% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.96MShares$139 Million0.08% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.09MShares$98.4 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$98.1 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.52B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...